Literature DB >> 12072680

Adrenal insufficiency in critically ill patients with human immunodeficiency virus.

Paul E Marik1, Kitonga Kiminyo, Gary P Zaloga.   

Abstract

OBJECTIVE: The adrenal gland is the endocrine organ most commonly involved in patients infected with human immunodeficiency virus (HIV). It is important to recognize patients with adrenal insufficiency, because this disorder may be fatal if untreated. The incidence of adrenal insufficiency in critically ill HIV-infected patients is unclear, partly because different criteria are used to diagnose adrenal insufficiency. To help clarify the incidence of adrenal insufficiency in HIV-infected critically ill patients, we compared the incidence based on the stress cortisol concentration, low-dose corticotropin stimulation test, and high-dose corticotropin stimulation test.
SETTING: Medical intensive care unit. PATIENTS: Twenty-eight critically ill patients with HIV, mean age 43 +/- 9 years; 20 were male; 54% died.
INTERVENTIONS: We performed a 1-microg (low-dose adrenocorticotropic hormone; LD-ACTH) and 249 microg (high-dose; HD-ACTH) corticotropin stimulation test in HIV-infected critically ill patients not receiving corticosteroids. According to results of the stress serum cortisol concentration and LD-ACTH and HD-ACTH tests, patients were classified as having adrenal insufficiency or as normal. The results of newly revised diagnostic criteria for adrenal insufficiency (i.e., stress cortisol concentration and cortisol response to LD-ACTH <25 microg/dL) were compared with the traditional criteria (i.e., stress cortisol level and response to HD-ACTH <18 microg/dL). In addition, the associations between adrenal insufficiency and the CD4 count, human cytomegalovirus antigenemia, and other risk factors for adrenal insufficiency were determined.
MEASUREMENTS AND MAIN RESULTS: When we used a stress cortisol concentration <18 microg/dL as the sole diagnostic threshold for diagnosis of adrenal insufficiency, 50% (14 of 28) of patients had adrenal insufficiency. The incidence was 75% (21 of 28) when we used a diagnostic threshold of <25 microg/dL for the stress cortisol concentration. When we used both the stress cortisol concentration and LD-ACTH test with a diagnostic cortisol threshold concentration <18 microg/dL, 21% (six of 28) had adrenal insufficiency. The incidence was 46% (13 of 28) when we used a cortisol diagnostic threshold concentration of <25 microg/dL. When we used both the stress cortisol concentration and the HD-ACTH stimulation test with a diagnostic cortisol threshold of <18 microg/dL, 7% (two of 28) had adrenal insufficiency. The incidence of adrenal insufficiency was 21% (six of 28) with a cortisol diagnostic threshold value of <25 microg/dL. Human cytomegalovirus antigenemia was the only variable assessed that was associated with adrenal insufficiency.
CONCLUSION: There is a high incidence of adrenal insufficiency in critically ill HIV-infected patients that varies with the criteria used to diagnose adrenal insufficiency. The LD-ACTH stimulation test is more sensitive than the high-dose test for diagnosing adrenal insufficiency in this population. Because of the high incidence of inadequate adrenal function, all critically ill HIV-infected patients should undergo an evaluation for adrenal insufficiency with the stress cortisol concentration and LD-ACTH stimulation tests.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12072680     DOI: 10.1097/00003246-200206000-00018

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  23 in total

1.  Serum cytokines and critical illness-related corticosteroid insufficiency.

Authors:  Yong Soo Kwon; Gee Young Suh; Kyeongman Jeon; So Young Park; So Yeon Lim; Won-Jung Koh; Man Pyo Chung; Hojoong Kim; O Jung Kwon
Journal:  Intensive Care Med       Date:  2010-07-28       Impact factor: 17.440

2.  Adrenal Insufficiency as a Paraneoplastic Syndrome in Gastric Adenocarcinoma.

Authors:  Bilal Farooqi; Hemant Goyal; Harold Katner
Journal:  J Gastrointest Cancer       Date:  2016-12

3.  Adrenal-exhaustion syndrome in patients with liver disease.

Authors:  Paul E Marik
Journal:  Intensive Care Med       Date:  2006-01-24       Impact factor: 17.440

4.  A prospective multicenter study of adrenal function in critically ill children.

Authors:  Kusum Menon; Roxanne E Ward; Margaret L Lawson; Isabelle Gaboury; James S Hutchison; Paul C Hébert
Journal:  Am J Respir Crit Care Med       Date:  2010-03-18       Impact factor: 21.405

5.  Prognostic value of relative adrenal insufficiency after out-of-hospital cardiac arrest.

Authors:  Frédéric Pene; Hervé Hyvernat; Vincent Mallet; Alain Cariou; Pierre Carli; Christian Spaulding; Marie-Annick Dugue; Jean-Paul Mira
Journal:  Intensive Care Med       Date:  2005-04-19       Impact factor: 17.440

6.  Hypothalamic pituitary abnormalities in tubercular meningitis at the time of diagnosis.

Authors:  Dinesh Kumar Dhanwal; Anirudh Vyas; Ashok Sharma; Alpana Saxena
Journal:  Pituitary       Date:  2010-12       Impact factor: 4.107

7.  The hepatoadrenal syndrome: a common yet unrecognized clinical condition.

Authors:  Paul E Marik; Timothy Gayowski; Thomas E Starzl
Journal:  Crit Care Med       Date:  2005-06       Impact factor: 7.598

8.  Functional adrenal insufficiency among critically ill patients with human immunodeficiency virus in a resource-limited setting.

Authors:  David B Meya; Elly Katabira; Marcel Otim; Allan Ronald; Robert Colebunders; Denise Njama; Harriet Mayanja-Kizza; Christopher C Whalen; Merle Sande
Journal:  Afr Health Sci       Date:  2007-06       Impact factor: 0.927

9.  Psychopharmacologic treatment of patients with HIV/AIDS.

Authors:  Stephen J Ferrando
Journal:  Curr Psychiatry Rep       Date:  2009-06       Impact factor: 5.285

10.  A prospective study on the incidence and predictive factors of relative adrenal insufficiency in Korean critically-ill patients.

Authors:  Yong Soo Kwon; Eunhae Kang; Gee Young Suh; Won-Jung Koh; Man Pyo Chung; Hojoong Kim; O Jung Kwon; Jae Hoon Chung
Journal:  J Korean Med Sci       Date:  2009-07-30       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.